Genesis™ Radiology Workspace is designed to optimize radiology workflows, with a goal to empower diagnosticians to work from virtually anywhere with diagnostic accuracy, anchored by the Genesis™ View, the foundation of the solution that is intended to streamline radiologists’ workflows. CHICAGO / Nov 25, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced the introduction of Genesis™ Radiology Workspace, a next-generation...Read more
Photonova Spectrai is the first in the next generation of spectral photon counting CT systems with 8-bins of energy resolution, powered by GE HealthCare’s proprietary Deep Silicon detector technology. The new 510(k) pending system is designed to simplify workflows with a one universal scan approach – aiming to boost efficiency and reduce complexity across multiple CT exams. Designed for impact across specialties, Photonova Spectra is...Read more
Veeva to deliver next generation customer engagement with agentic AI for Roche PLEASANTON, Calif., Nov. 24, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM. "Roche and Veeva have partnered for many years," said Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the...Read more
Total Revenues of $811.2M, up 16% Year Over Year Subscription Services Revenues of $682.5M, up 17% Year Over Year PLEASANTON, Calif., Nov. 20, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2025. "Continuing to lead through innovation, Veeva AI delivers on our vision...Read more
Creates a fully-connected, cloud-first imaging ecosystem spanning high-growth outpatient and ambulatory, teleradiology and hospital settings Brings AI and workflow orchestration, cloud PACS, and image sharing, all in a SaaS business model, to GE HealthCare Offers attractive return profile given high growth, recurring revenue base and strong margin profile of Intelerad, along with valuable synergies Combines the extensive AI portfolio...Read more
CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its mission to deliver the highest quality cardiovascular care for patients. CVAUSA currently performs approximately 85,000 cardiac positron emission tomography (PET) procedures annually, highlighting the potential opportunity for Flyrcado as adoption grows. GE HealthCare remains committed to driving innovation and...Read more
CHICAGO / Nov 16, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunities. He will also comment on questions that have...Read more
New applications include Veeva LIMS Basics and PromoMats Basics to drive speed and growth PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 100 biotechs have selected Veeva Basics to advance operations across clinical, regulatory, and quality. A growing number of biotechs in the U.S. and Europe are establishing a foundation for growth with a simple and standard industry-leading...Read more
Total revenues for the third quarter 2025 increased 10% to $69.7 billion Shareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per share Adjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 The Cigna Group announced a new rebate-free pharmacy benefit model designed to lower...Read more
Revenue growth was 6% and Organic revenue growth* was 4% year-over year, driven by Europe, the Middle East and Africa (EMEA) and the U.S. Organic orders growth was 6% with growth across all segments Net income margin was 8.7%; Adjusted earnings before interest and taxes (EBIT) margin* was 14.8% Diluted earnings per share (EPS) were $0.98; Adjusted EPS* was $1.07 Cash flow from operating activities was $593 million; Free cash flow* was...Read more
Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, Adjusted Earnings $2.92 Per Share Cash Flows from Operations were $5.9 Billion, or 2.3x Net Income Raises Full Year 2025 Earnings Outlook to at least $14.90 Per Share; Adjusted Earnings of at least $16.25 Per Share - / Oct 28, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) reported third quarter 2025 results,...Read more
NASHVILLE, Tenn. / Oct 27, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general...Read more
Raises 2025 Guidance NASHVILLE, Tenn. / Oct 24, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643...Read more
Executing with discipline to improve affordability and elevate the member experience 3Q 2025 operating revenue of $50.1 billion, up 12.0% from 3Q 2024 3Q 2025 diluted EPS1 of $5.32; adjusted diluted EPS2 of $6.03 Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively Returned $3.3 billion of capital to shareholders year-to-date INDIANAPOLIS / Oct 21,...Read more
Queen’s and a nationally recognized academic medical center to provide clinical expertise to enhance GE HealthCare’s forthcoming software solution New software solution will use AI and predictive analytics to recommend actions and help care teams improve quality of care, patient flow, and maximize resources CHICAGO / Oct 20, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced collaborations with two leading U.S. health...Read more
PLEASANTON, Calif. and MIAMI, Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vista. Open Vista will use AI to increase patient access to clinical trials, accelerate drug discovery through better understanding of unmet needs, and improve understanding and adoption of existing approved medicines to provide better patient...Read more
Deep, industry-specific agents planned for availability starting this December PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and across R&D and quality in 2026. Veeva AI adds agentic AI to the Veeva Vault Platform and deep, industry-specific agents for Veeva applications in all major areas, including...Read more
Informed by clinicians and built on clinical insights, the solution provides care teams with real-time1 insights designed to streamline perinatal workflows and support timely clinical decision-making. Developed in collaboration with HCA Healthcare, one of the nation’s leading healthcare providers, this solution includes clinical input that helps ensure practical functionality that will help clinicians stay focused on patient care. The...Read more
Carestation 850 is designed to help health systems navigate the evolving landscape of anesthesia care now and in the future with an ergonomic design, continuously optimized algorithms, adaptable technologies and sustainable practices. With the goal of enhancing clinical precision, Carestation 850 features tools and customizable applications that are designed to help adapt to the needs of each patient, from neonates to the elderly. GE...Read more
For next-generation CRM with deep, industry-specific AI agents PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM. "Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," said Greg Meyers, executive vice president, chief digital and technology officer at Bristol Myers Squibb....Read more
NASHVILLE, Tenn. / Sep 10, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, and the HCA Healthcare Foundation today announced they will continue their collaboration with the American Heart Association on their Getting to the Heart of Stroke™ initiative through $3.9 million in funding and support. This builds upon the collaboration announced in 2022 focused on deepening the heart-brain...Read more
The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis of brain MRI icometrix’s icobrain platform – a comprehensive set of solutions for neurological disease analysis – includes icobrain aria, the first AI Computer-Aided Detection and Diagnosis FDA 510(k) cleared solution for detecting known side...Read more
GE HealthCare’s agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the reach of Flyrcado. Through their nearly 225 U.S. customers, CDL and CardioNavix support more than 220,000 cardiac PET procedures annually. This agreement builds the capabilities needed to support Flyrcado’s growth in outpatient cardiac PET imaging by pairing CardioNavix’s comprehensive program setup, workflow, and...Read more
CHICAGO / Aug 29, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently received CE Mark and U.S. FDA 510(k)...Read more
PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company's commitment to accelerating the development of new medicines for patients with serious diseases. "In...Read more
Total Revenues of $789.1M, up 17% Year Over Year Subscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025. "It's exciting to see our vision of connected software, data, and business...Read more
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Aug. 18, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data,...Read more
Trained providers to screen, enroll eligible members to receive evidence-based nutrition and dietary services. INDIANAPOLIS / Aug 18, 2025 / Business Wire / Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and...Read more
Total revenues for the second quarter 2025 increased 11% to $67.2 billion Shareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per share Adjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna...Read more
Revenue growth was 3% year-over-year; Organic revenue growth* was 2% Net income margin was 9.7% versus 8.9% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 14.6% versus 15.3% Diluted earnings per share (EPS) were $1.06 versus $0.93 for the prior year; Adjusted EPS* was $1.06 versus $1.00 Cash flow from operating activities was $94 million versus $(119) million for the prior year; Free cash flow* was...Read more
Full Year 2025 Revenue Outlook of $445.5 Billion to $448.0 Billion Full Year 2025 Earnings Outlook of at least $14.65 Per Share, Adjusted Earnings of at least $16.00 Per Share Second Quarter Earnings were $3.74 Per Share, Adjusted Earnings were $4.08 Per Share Jul 29, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) reported second quarter 2025 results and updated its 2025 outlook. “UnitedHealth Group has embarked on a rigorous...Read more
Raises 2025 Guidance NASHVILLE, Tenn. / Jul 25, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): Revenues increased 6.4 percent to $18.605 billion Net income attributable to HCA Healthcare, Inc. increased 13.1 percent to $1.653...Read more
Definium™ Pace Select ET, a new floor-mounted digital X-ray system, enables access to affordable, high-quality medical imaging technology while easing workflow burdens in high-volume environments This new X-ray system, designed to act as a personal assistant for technologists, provides automation of in-room workflows and motorization of manual, repetitive tasks to increase throughput and reduce technologist learning curve CHICAGO /...Read more
PLEASANTON, Calif., July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 countries with Veeva OpenData and Veeva Network. Accurate and comprehensive customer reference data from OpenData will equip Boehringer Ingelheim's teams with the insights needed to engage healthcare professionals (HCPs) with relevant information,...Read more
2Q 2025 operating revenue of $49.4 billion, up 14.3% from 2Q 2024 2Q 2025 diluted EPS1 of $7.72; adjusted diluted EPS2 of $8.84 Revising FY 2025 adjusted diluted EPS guidance to approximately $30.00 Returned $2.0 billion of capital to shareholders year-to-date INDIANAPOLIS / Jul 17, 2025 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made...Read more
NASHVILLE, Tenn. / Jul 11, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare’s board of directors increases from nine to ten members. Mr. Chidsey will serve as a member of HCA Healthcare’s audit and compliance committee,...Read more
AWS compute, database, and global infrastructure support Veeva’s industry cloud for life sciences PLEASANTON, Calif. & SEATTLE / Jun 25, 2025 / Business Wire / Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Veeva Systems (NYSE: VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva...Read more
The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid in the brain This approval also enables clinicians to use Vizamyl to monitor patient response to anti-amyloid therapies Other updates include now enabling the use of Vizamyl to predict development of dementia or other cognitive decline due to Alzheimer’s disease,...Read more
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT) technology for new clinical pathways to help improve patient outcomes. Total body PET/CT technologyi is designed with the goal of supporting personalized medicine practices like theranostics, improve healthcare system efficiency, and provide scalable solutions for imaging practices and...Read more
GE HealthCare expands precision care capabilities with its first combined software release with MIM Encore™, helping enhance digital imaging and workflow solutions across oncology, cardiology, and neurology. The software solution was designed to help tackle key healthcare challenges like improving efficiency, streamlining cross-departmental communication, and reducing manual workloads. Now powered with additional GE HealthCare features...Read more
New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeys As new data show 4 out of 5 U.S. adults don't feel confident in their knowledge of health insurance benefits, new digital tools use clear, conversational language to boost understanding and help customers get more out of their coverage BLOOMFIELD, Conn., June 12, 2025 /PRNewswire/ -- Cigna Healthcare, the...Read more
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to...Read more
Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery PLEASANTON, Calif. and NASHVILLE, Tenn., June 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and Sarah Cannon Research Institute (SCRI) today announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI's more than 200 research site locations. SCRI is adopting Veeva Clinical Platform to...Read more
PLEASANTON, Calif., May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY. Paul Shawah, EVP Strategy, is presenting on Tuesday, June 3, 2025, at 10:50 a.m. Eastern Time. William Blair 45th Annual Growth Stock Conference, Chicago, IL. Brian Van Wagener, CFO, is presenting on Wednesday,...Read more
Total Revenues of $759.0M, up 17% Year Over Year Subscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif., May 28, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025. "I consider this our best first quarter ever. We executed with speed,...Read more
Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and...Read more
CleaRecon DL receives 510(k) clearance and CE mark, paving the way for clinicians to use 3D image guidance technologies to their full potential with the goal of achieving better clinical and operational outcomes AI-driven solution advances image quality and improves clinical confidence, encouraging adoption of cone-beam computed tomography CHICAGO / May 15, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch...Read more
The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound enhancing agent available in the U.S. ARLINGTON HEIGHTS, Ill. / May 13, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s...Read more
The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s fetal monitoring and digital perinatal surveillance platforms that have a 60-year history of innovation and industry firsts. Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress, potentially...Read more
SIGNA™ Sprint, a new wide bore 1.5T MRI scanner, is designed to provide power previously unattainable at 1.5T, for clarity in cardiology and oncology imaging Advanced high-performance gradient technology leverages built-in AI solutions designed to enable clear, fast imaging for improved workflow HONOLULU / May 12, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium...Read more
The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes CHICAGO / May 02, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria....Read more
Total revenues for the first quarter 2025 increased 14% to $65.5 billion Shareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per share Adjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share 2025 adjusted income from operations1,2 increased to at least $29.60 per share2 BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group...Read more
Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7% Diluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90 Cash flow from operating activities was $250 million versus $419 million for the prior year; Free cash...Read more
Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial PLEASANTON, Calif., April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and...Read more
NASHVILLE, Tenn. / Apr 25, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled...Read more
1Q 2025 operating revenue of $48.8 billion, up 15.4% from 1Q 2024 1Q 2025 adjusted operating gain1 of $3.3 billion, up 4.1% from 1Q 2024 1Q 2025 diluted EPS2 of $9.61; adjusted diluted EPS1 of $11.97 Reaffirm FY 2025 adjusted diluted EPS1 of $34.15 to $34.85 Returned $1.3 billion of capital to shareholders in 1Q 2025 INDIANAPOLIS / Apr 22, 2025 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025...Read more
Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 - / Apr 17, 2025 / Business Wire /...Read more
This strategic research collaboration – known as a Care Innovation Hub – will bring together clinicians and researchers from Cincinnati Children’s with clinical scientists and engineers from GE HealthCare to work together on projects that aim to develop the next generation of pediatric medical imaging in MR, CT, molecular imaging, ultrasound, and more. Research developed as part of the collaboration will aim to improve the consistency of...Read more
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors...Read more
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, is positioned to enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Kevin O’Neill, President & CEO of GE HealthCare’s Pharmaceutical Diagnostics segment, will...Read more
GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes. Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by 2030.iii The average number of cardiac...Read more
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, is now available in select U.S. markets and has been granted traditional pass-through payment status by the U.S. Centers for Medicare and Medicaid. CHICAGO / Mar 27, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the...Read more
The latest Invenia ABUS is designed to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology Invenia ABUS Premium features new integrated Verisound AI and AI Assistant, which ensure faster and reproducible scanning and reading with extraordinary image quality The non-invasive ultrasound technology, equipped with a novel Reverse Curve transducer and separate acquisition and reading...Read more
Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing burden on healthcare professionals. SAN JOSE, Calif. / Mar 18, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to...Read more
AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab can enhance efficiency and precision care for multiple types of cardiac procedures CHICAGO / Mar 17, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and...Read more
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and PLEASANTON, Calif., March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine...Read more
Fiscal Year 2025 Total Revenues of $2,746.6M, up 16% Year Over Year Q4 Total Revenues of $720.9M, up 14% Year Over Year Fiscal Year 2025 Subscription Services Revenues of $2,284.7M, up 20% Year Over Year Q4 Subscription Services Revenues of $608.6M, up 17% Year Over Year PLEASANTON, Calif., March 5, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life...Read more
A new cloud-suite of enterprise imaging solutions, the Genesis portfolio, is designed to help improve patient care coordination, reduce operational costs, and maintain robust security standards Allows healthcare providers to more easily store, access, and manage large volumes of medical images from anywhere, anytime Demonstrates GE HealthCare’s commitment to increasing the number of cloud-enabled product offerings by 2028, generating...Read more
Freelium, a helium-freei sealed magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance Leveraging GE HealthCare’s proven lightweight, intelligent magnet technology, Freelium will be optimized to seamlessly integrate with future technological advancements and upgrade options, offering flexibility and reliability for imaging...Read more
The first patient doses of GE HealthCare’s new FDA-approved PET radiotracer, Flyrcado™ (flurpiridaz F 18) injection, are being administered at early adopter sites around the United States. First-of-its-kind radiopharmaceutical, Flyrcado, a PET myocardial perfusion imaging (MPI) agent, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, the predominant procedure...Read more
Fourth Quarter 2024 Revenue growth was 2% year-over-year; Organic revenue growth* was 2% Net income margin was 13.5% versus 7.7% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 18.7% versus 16.1% Diluted earnings per share (EPS) were $1.57 versus $0.88 for the prior year; Adjusted EPS* was $1.45 versus $1.18 Cash flow from operating activities was $913 million versus $1.1 billion for the prior year;...Read more
New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027i Demand for CT and X-Ray contrast media, used to enhance medical imaging procedures globally, is estimated to double in the next ten yearsii Investment will create additional capacity to cater for growing demand, while offering increased flexibility and resiliency for security of...Read more
Total revenues for 2024 increased 27% to $247.1 billion Shareholders' net income for 2024 was $3.4 billion, or $12.12 per share Adjusted income from operations1 for 2024 was $7.7 billion, or $27.33 per share 2025 adjusted income from operations1,2 is projected to be at least $7.9 billion, or at least $29.50 per share Board of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of...Read more
Latest Voluson Expert 22, 20 and 18 ultrasound systems harness artificial intelligence and advanced tools and software for more efficient assessments Voluson Expert Series delivers elevated performance, with focus on first trimester to reveal clearer anatomical details, aiding earlier detection and boosting diagnostic confidence CHICAGO / Jan 28, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced it has received...Read more
NASHVILLE, Tenn. / Jan 24, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an...Read more
Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementation PLEASANTON, Calif. and DEERFIELD, Ill., Jan. 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and Zifo today announced a product partnership to help biopharmas modernize quality control (QC) operations. By bringing together Veeva LIMS with Zifo's data integration and management platform, qcKen, companies can...Read more
4Q 2024 operating revenue of $45.0 billion; FY 2024 of $175.2 billion 4Q 2024 diluted EPS1 of $1.81; adjusted diluted EPS2 of $3.84 FY 2024 diluted EPS1 of $25.68; adjusted diluted EPS2 of $33.04 Projected FY 2025 GAAP diluted EPS1 to be in the range of $30.40 to $31.10 Projected FY 2025 adjusted diluted EPS2 to be in the range of $34.15 to $34.85 Quarterly dividend increased by 5% to $1.71 per share INDIANAPOLIS / Jan 23, 2025 /...Read more
Revenues of $400.3 Billion Grew 8% Year-Over-Year Domestic Consumers Served by UnitedHealthcare Grew 2.1 Million Value-Based Care Patients Served by Optum Grew 600,000 Cash Flows from Operations were $24.2 Billion or 1.6x Net Income Full Year, Fourth Quarter Net Earnings were $15.51, $5.98 Per Share Full Year, Fourth Quarter Adjusted Net Earnings were $27.66, $6.81 Per Share Company Affirms 2025 Performance Outlook - / Jan 16,...Read more
New joint research program combines UCSF’s advanced clinical and research teams with GE HealthCare’s technical and engineering expertise to develop solutions that directly impact patient care. The collaboration aims to address two of the most prevalent disease states worldwide, neurodegenerative disease and cancer, by increasing accessibility of imaging, driving clinical impact and translating techniques to diagnose and treat these...Read more
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians with access to technology advances and innovations. It will also drive ongoing, comprehensive training and education, fostering future healthcare professionals representing the diverse communities they serve. Sutter Health, one of the top integrated health delivery systems in the country...Read more
Total Revenues of $699.2M, up 13% Year Over Year Subscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the...Read more
More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare is at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit clinicians and patients with the latest technologies and solutions. CHICAGO / Dec 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC)...Read more
CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data CHICAGO / Dec 03, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam...Read more
GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Acquisition positions NMP to become partner of choice for global innovators looking to bring novel...Read more
New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL accelerates workflow while improving diagnostic confidence and patient comfort. CHICAGO / Dec 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging...Read more
Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product introductions reflect GE HealthCare’s increased R&D investment since 2022 CHICAGO / Dec 01, 2024 / Business Wire / At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare...Read more
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE